What is the current share price of Sai Life Sciences Limited (SAILIFE)?

As of the latest market update, Sai Life Sciences Limited (SAILIFE) is trading at ₹1,218.1. The stock has moved 3.12% up in the recent session.

What is the technical sentiment for SAILIFE stock?

Based on our proprietary technical analysis, the current signal for SAILIFE is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Sai Life Sciences Limited?

Sai Life Sciences Limited has seen a 52-week high of ₹1,244.2 and a 52-week low of ₹716.6. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Sai Life Sciences Limited belong to?

Sai Life Sciences Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of SAILIFE?

Sai Life Sciences Limited (SAILIFE) has a market capitalization of approximately ₹25.78K Cr. This classifies it as a small cap stock in the Indian market.

SAILIFE

NSE

Sai Life Sciences Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹1,218.10

36.90 (3.12%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹25.78K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

71.8

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹716.6+70.0%

52W High₹1,244.2-2.1%

Current Price

₹1,218.10

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹974.48

Upper Circuit₹1,461.72

Reference Price

₹1,218.10

Investment Checklist

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹928.5

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1040.65

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

Composite score 49.36 (BUY) with 82.4% confidence

Volume divergence: Bearish (price up, volume down)

Technical Analysis

Analysis from 2026-06-12

Confidence

82%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

1156.8

EMA50

1097.95

EMA200

965.43

Price Action

UPTREND

BULLISH

Higher Highs7

Higher Lows6

Lower Highs2

Lower Lows3

Support & Resistance Levels

Resistance (Above)

No recent resistance detected

Support (Below)

₹1184.80

₹1139.40

₹1109.20

₹1084.00

₹1029.80

Volume Analysis

TrendDECREASING

Change-65.10%

Unusual VolumeNo

Divergence Detected

Bearish (price up, volume down)

Stop Loss Levels

Fixed Risk

1% Risk₹1205.92

3% Risk₹1181.56

5% Risk₹1157.19

7% Risk (Custom)

₹1132.83

Technical Levels

1x ATR (Volatility)₹1171.03

2x ATR (Swing)₹1123.96

3x ATR (Trend)₹1076.89

Immediate Support₹1184.80

Moving Averages

EMA 9 (Short-term)₹1185.30

EMA 20 (Medium-term)₹1156.80

EMA 50 (Trend)₹1097.95

EMA 200 (Long-term)₹965.43

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹439.8 Cr	₹545.3 Cr	₹496.4 Cr	₹556.5 Cr
Net Profit	₹53.9 Cr	₹88.3 Cr	₹60.5 Cr	₹100.4 Cr
EPS	₹2.89	—	₹2.90	₹4.77
Operating Profit	₹128.9 Cr	₹167.2 Cr	₹130.8 Cr	₹187.9 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Announcements

Latest updates

View All

Date	Description	Link
11 Jun 2026	Analysts/Institutional Investor Meet/Con. Call Updates
06 Jun 2026	Disclosure under SEBI Takeover Regulations
27 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
21 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
17 May 2026	Copy of Newspaper Publication

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
14 May 2026	Financial Results
14 May 2026	Board Meeting Intimation	XBRL
05 Feb 2026	Board Meeting Intimation	XBRL
05 Feb 2026	Financial Results
06 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 5 Qtrs)

Latest News

News for SAILIFE

View All

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

positive

ET Markets - Industry 23h ago

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.

ALIVUSANURASGLOBALJFLLIFEJFL-RERPGLIFESAILIFESUVENVITALChemicalsConsumer Services

Read full story

positive

LiveMint - Markets 1d ago

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.

ALIVUSANURASFOCUSJFLLIFEJFL-RERPGLIFESAILIFESUVENChemicalsConsumer Durables

Read full story

positive

Business Standard - Markets 2d ago

Analysts project up to 17% upside in healthcare stocks trading at new highs

Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.

ALIVUSAPOLLOAPOLLOHOSPASTERDMHCGHCG-REHEALTHCAREHEALTHYJFLLIFEJFL-REJLHLRPGLIFESAILIFESUVENCapital GoodsFinancial Services

Read full story

SAILIFE

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 5 Qtrs)

Latest News

News for SAILIFE

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Analysts project up to 17% upside in healthcare stocks trading at new highs

Frequently Asked Questions

What is the current share price of Sai Life Sciences Limited (SAILIFE)?

What is the technical sentiment for SAILIFE stock?

What is the 52-week high and low for Sai Life Sciences Limited?

Which sector does Sai Life Sciences Limited belong to?

What is the market capitalization of SAILIFE?